LCN2 and acute kidney injury: Although several novel biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), interleukin18 (IL-18), have been introduced to identify early AKI before creatinine rise, the utility is confined to research and clinical applicability is impeded (4–6).